Director, Regulatory Affairs Advertising and Promotion Daiichi Sankyo, Inc.Director, Regulatory Affairs Advertising and PromotionBasking Ridge, NJ$184,240–$276,360 / yearFull timeThe Director, Regulatory Affairs Advertising and Promotion (RAAP) provides senior strategic and tactical regulatory leadership for U.S. promotional and selected non-promotional communications across assigned products, therapeutic areas, and key business initiatives within the Daiichi Sankyo portfolio, including alliance assets. Interpret evolving FDA regulations, guidances, enforcement trends, compliance letters, and relevant industry developments, including ambiguous or precedent-setting issues, and translate them into actionable regulatory strategy and business guidance.
Associate Director, Regulatory Affairs Advertising & Promotions Tris Pharma IncAssociate Director, Regulatory Affairs Advertising & PromotionsMonmouth Junction, NJ$180,000–$225,000 / yearTris Pharma, Inc. (www.trispharma.com) is a leading privately-owned US biopharmaceutical company focused on development and commercialization of innovative medicines in ADHD, spectrum disorders, anxiety, pain and addiction addressing unmet patient needs. Bachelors degree in life sciences, pharmacy, medicine or a related discipline and minimum of 7 years' experience as a regulatory reviewer of advertising and promotional materials in the pharmaceutical, biotechnology or related industry REQUIRED.
Manager, Indirect Sourcing, Retail & Promotions L'Oreal USA IncManager, Indirect Sourcing, Retail & PromotionsBerkeley Heights, NJBerkeley Heights, NJ. New Jersey.
NewTraining and Promotion Representative I Brightstar LotteryTraining and Promotion Representative INJ Statewide, NJRemote$43,264–$73,882 / yearSupported by industry leaders Brightstar Lottery and Scientific Games, NSNJ offers the opportunity to collaborate with experts, contribute to high‑impact initiatives, and support one of the nation’s most successful and responsible lottery programs. IGT is committed to sustaining a workforce that reflects the diversity of the global customers and communities we serve, and to creating a fair and inclusive culture that enables all our employees to feel valued, respected and engaged.
Associate Director, Regulatory Affairs Advertising and Promotion Recordati SpAAssociate Director, Regulatory Affairs Advertising and PromotionBridgewater, NJ$137,600–$180,000 / yearRecordati Rare Diseases, Inc. (RRD) develops high-impact therapies for rare diseases, focusing on providing treatments to underserved communities in the U.S. Our mission is to mitigate the impact of rare diseases through increased awareness, better diagnoses, and improved treatment access in endocrinology, metabolic, hematology and oncology franchises. This role is responsible for supporting regulatory review and activities related to advertising / promotion of our marketed pharmaceutical products in 1 or 2 of the following therapeutic areas: oncology, endocrinology, hematology.
NewDigestive Health Trade Promotion Manager, Customer Strategy Haleon PlcDigestive Health Trade Promotion Manager, Customer StrategyWarren, NJ$108,429–$149,089 / yearLead Quarterly Promotional Reviews with Customer Strategy and Brand to evaluate current POS promotional trends and trade offer effectiveness; identify gaps/upside in the 4Ps by leveraging multiple data sources such as Numerator and IRI, inclusive of top competitor trends and insights, and proactively communicate upcoming plans. Present on promotional topics in key Haleon engagements (Annual Business Meeting, Go-To-Market meetings, customer team planning sessions, etc.) with periodic opportunities to interact with customer directly (retailer buying teams).
NewDirector, Regulatory Affairs Advertising & Promotion Acadia Pharmaceuticals IncDirector, Regulatory Affairs Advertising & PromotionPrinceton, NJ$193,400–$241,800 / yearThe position partners closely with cross-functional teams to support the timely approval and distribution of promotional and disease state materials, serves as the primary liaison with the FDA''s Office of Prescription Drug Promotion (OPDP) for advertising and promotional submissions, and contributes to labeling strategies for regulatory submissions across Acadia''s product portfolio. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer's disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs.